
Gold-standard stroke care, available to every patient, regardless of where they live. That’s what @remedyrobotics is building, and we’re very proud to lead its $62 million Series B and continue backing this exceptional team. 🥂
... also, we're proud at @DCVC to have led @remedyrobotics first round of financing and incredibly excited for the $62m in fresh capital to help them conduct their pivotal trial


















